logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
F

Fabrice André

gustave roussy

148H-index
1.8KPaper Count
10.3WCitation Count
Published Papers 541
Publication Date
logo
Rb-driven transcription limits its tumour-suppressive effects in breast cancer
errNature
IF48.5
err2026-08-12
err0
errOAAI
errApril C. Watt; Antonio Ahn; Catherine Blyth; Julia R. Dixon-Douglas; Krutika Ambani; Rhiannon Coulson; Michael Taylor; Keefe T. Chan; Catherine Dietrich; Brendan E. Russ; Susanne Ramm; Christabella A. Mahendra; Kun-Hui Lu; Nichelle Pires; Jesus Garcia-Sannicolas; Olivia Voulgaris; Sheena Nunag; Ching-Seng Ang; Mark A. Dawson; Elgene Lim; Monica Arnedos; Sarat Chandarlapaty; Fabrice André; Shom Goel
errShare
errSave
SparseXMIL: Leveraging sparse convolutions for context-aware and memory-efficient classification of whole slide images in digital pathology
errMedical Image Analysis
IF11.8
err2026-03-17
err0
PREAI
errLoïc Le Bescond; Marvin Lerousseau; Fabrice André; Hugues Talbot
errShare
errSave
Novae: a graph-based foundation model for spatial transcriptomics data
errNature Methods
IF32.1
err2025-12-10
err0
PREAI
errQuentin Blampey; Hakim Benkirane; Nadège Bercovici; Kevin Mulder; Grégoire Gessain; Florent Ginhoux; Fabrice André; Paul-Henry Cournède
errShare
errSave
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the Recurrence Score® in node-positive breast cancer: independent validation in the PACS-01 trial.
errEuropean Journal of Cancer
IF7.1
err2025-12-01
err0
PREAI
errFrédérique Penault-Llorca; Amelie Lusque; Thomas Filleron; Kevin Tran; Lili Du; Rick Baehner; Florence Dalenc; Magali Lacroix-Triki; Thomas Bachelot; Fabrice Andre; Pascal Boucher; Jérôme Lemonnier; W. Fraser Symmans
errShare
errSave
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
errAnnals of Oncology
IF65.4
err2025-11-18
err0
PREAI
errC. Saura; J. Cortés; S. Modi; S.-B. Kim; E. Hamilton; S.A. Hurvitz; I.E. Krop; G. Curigliano; H. Iwata; S.-A. Im; P. Herbolsheimer; M. Karnoub; A. Boran; Y. Kuwahara; A. Egorov; F. André
errShare
errSave
Rheumatoid arthritis, cardiovascular imaging and disease associations in UK Biobank
errEuropean Heart Journal
IF35.6
err2025-11-05
err0
PREAI
errD Condurache; J Salatzki; S Dangelo; A M Salih; L Szabo; A Mahmood; E M Curtis; S E Petersen; A Altmann; N Frey; F Andre; N C Harvey; Z Raisi-Estabragh
errShare
errSave
Promoting equitable access to financial services to end financial discrimination against cancer survivors in Europe: scientific and ethical reasons
errESMO Open
IF8.3
err2025-10-27
err0
errOAAI
errF. André; D. Soldato; I. Vaz-Luis; A. Cervantes; S. Peters; N. Harbeck; E. de Azambuja; J.-Y. Blay
errShare
errSave
Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study
errBritish Journal of Cancer
IF6.8
err2025-10-21
err0
PREAI
errGarazi Ruiz de Azua; Idlir Licaj; Sandrine Pinto; Julie Havas; Antonio Di Meglio; Ines Vaz-Luis; Barbara Pistilli; Fabrice André; Anne-Laure Martin; Sibille Everhard; Christelle Jouannaud; Marion Fournier; Philippe Rouanet; Asma Dhaini-Merimeche; Baptiste Sauterey; Mario Campone; Carole Tarpin; Florence Lerebours; Agnès Dumas; Gwenn Menvielle
errShare
errSave
An Unforeseen, Existential Threat to Oncological Research in Europe
errAnnals of Oncology
IF65.4
err2025-09-26
err0
PREAI
errJ-Y. Blay; A. Cervantes; F. André; S. Peters; N. Harbeck; E. Azambuja; G. Curigliano
errShare
errSave
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis
errBritish Journal of Cancer
IF6.8
err2025-09-11
err0
PREAI
errAbderaouf Hamza; Pierre Gestraud; Maryam Karimi; Alicia Tran-Dien; Laurène Syx; Sophie Vacher; Quentin Peretti; Ludovic Lacroix; Valery Attignon; Isabelle Soubeyran; Pascal Jézéquel; David Planchard; Samia Melaabi; Trenton Dailey-Chwalibóg; Marta Jimenez; Stefan Michiels; Nicolas Servant; Christophe Le Tourneau; Nicolas Girard; Fabrice André; Benjamin Besse; Maud Kamal; Fabrice Barlesi; Ivan Bièche
errShare
errSave
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2− Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial
errClinical Pharmacology & Therapeutics
IF5.5
err2025-08-24
err0
PREAI
errEnora Laas; Anne-Sophie Hamy; Thomas Bachelot; Paul Gougis; Jérôme Lemonnier; Fabrice André; David Cameron; Judith Bliss; Sylvie Chabaud; Anne-Claire Hardy-Bessard; Magali Lacroix-Triki; Djelila Allouache; Marc Debled; Mario Campone; Laurence Venat-Bouvet; Paul Cottu; Mathilde Martinez; Julien Grenier; Florence Dalenc; Elise Dumas; Fabien Reyal; Bernard Asselain; Frédérique Penault-Llorca; Francis Lévi; Sylvie Giacchetti
errShare
errSave
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial
errNature Cancer
IF28.5
err2025-06-30
err0
errOAAI
errEdith Borcoman; Bastien Cabarrou; Miguel Francisco; Frédéric Bigot; François Ghiringhelli; Damien Vansteene; François Legrand; Maral Halladjian; Célia Dupain; Olivia Le Saux; Clelia Coutzac; Christian Borel; Raphael Chaltiel; Benoit You; Carlos Gomez-Roca; Sophie Cousin; Elodie Coquan; Aurélien Lambert; Esma Saada-Bouzid; Xavier Durando; Mathilde Saint-Ghislain; Gianmaria Frige; Elena Guerini-Rocco; Maria Manuela Tonini; Ivan Bièche; Zahra Castel-Ajgal; Grégoire Marret; Marie-Paule Sablin; Emmanuelle Jeannot; Fabrice Andre; Thomas Filleron; Marta Jimenez; Luca Mazzarella; Nicolas Servant; Maud Kamal; Christophe Le Tourneau
errShare
errSave
Bridging tumour classification and treatment
errlancet oncology
IF0
err2025-06-30
err0
PREAI
errVivek Subbiah; Benedikt Westphalen; Guiseppe Curigliano; Fabrice Andre
errShare
errSave
Reply to Letter to the Editor: ‘A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases’ by Y. Liu & C. Zhang
errAnnals of Oncology
IF65.4
err2025-06-10
err0
PREAI
errF. André; K. Tecson; A. Egorov
errShare
errSave
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial
errESMO OPEN
IF8.3
err2025-05-01
err0
errOAAI
errSaint-Ghislain, M.; Chabaud, S.; Dalenc, F.; Allouache, D.; Cameron, D.; Martinez, M.; Grenier, J.; Barthelemy, P.; Brunt, M.; Kaluzinski, L.; Mailliez, A.; Legouffe, E.; Hardy-Bessard, A. -c.; Giacchetti, S.; Mouret-Reynier, M. -a.; Canon, J. -l.; Bliss, J.; Lemonnier, J.; Andre, F.; Bachelot, T.; Cottu, P.
errShare
errSave
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption
errBREAST CANCER RESEARCH
IF5.6
err2025-02-07
err0
errOAAI
errLopez, Morgane; Spehner, Laurie; Andre, Fabrice; Viot, Julien; Seffar, Evan; Marguier, Amelie; Curtit, Elsa; Meynard, Guillaume; Dobi, Erion; Ladoire, Sylvain; Boidot, Romain; Loyon, Romain; Derangere, Valentin; Bidard, Francois-Clement; Borg, Christophe; Mansi, Laura; Kroemer, Marie
errShare
errSave
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing
errBRIEFINGS IN BIOINFORMATICS
IF7.7
err2025-01-18
err0
errOAAI
errGuille, Arnaud; Adelaide, Jose; Finetti, Pascal; Andre, Fabrice; Birnbaum, Daniel; Mamessier, Emilie; Bertucci, Francois; Chaffanet, Max
errShare
errSave
Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2,-3, and-7 trials
errANNALS OF ONCOLOGY
IF65.4
err2025-01-01
err2
errOAAI
errAndre, F.; Solovieff, N.; Su, F.; Bardia, A.; Neven, P.; Yap, Y. S.; Tripathy, D.; Lu, Y. -S.; Slamon, D.; Chia, S.; Joshi, M.; Chakravartty, A.; Lteif, A.; Taran, T.; Arteaga, C. L.
errShare
errSave
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference
errONCOIMMUNOLOGY
IF6.3
err2024-12-18
err0
errOAAI
errLaurent, Pierre-Antoine; Andre, Fabrice; Bobard, Alexandre; Deandreis, Desiree; Demaria, Sandra; Depil, Stephane; Eichmueller, Stefan B.; Fernandez-Palomo, Cristian; Foijer, Floris; Galluzzi, Lorenzo; Galon, Jerome; Guckenberger, Matthias; Harrington, Kevin J.; Herrera, Fernanda G.; Huber, Peter E.; Italiano, Antoine; Karam, Sana D.; Kroemer, Guido; Lambin, Philippe; Leuschner, Carola; Mantovani, Alberto; Meylan, Etienne; Mondini, Michele; Pittet, Mikael J.; Pouget, Jean-Pierre; Remon, Jordi; Sorensen, Claus S.; Sotiriou, Christos; Vanpouille-Box, Claire; Weichselbaum, Ralph R.; Welsh, James W.; Zitvogel, Laurence; Formenti, Silvia C.; Deutsch, Eric
errShare
errSave
A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err2
errOAAI
errAndre, F.; Cortes, J.; Curigliano, G.; Modi, S.; Li, W.; Park, Y. H.; Chung, W. -p.; Kim, S. -b.; Yamashita, T.; Pedrini, J. L.; Im, S. -a.; Tseng, L. -m.; Harbeck, N.; Krop, I.; Nakatani, S.; Tecson, K.; Ashfaque, S.; Egorov, A.; Hurvitz, S. A.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Guido Kroemer
H-index: 283 · Papers: 2.3K
D
Didier Raoult
H-index: 198 · Papers: 4.0K
G
Gabriel N. Hortobágyi
H-index: 187 · Papers: 1.9K
D
David Haussler
H-index: 175 · Papers: 720
M
Mark J. Smyth
H-index: 172 · Papers: 1.4K
View more